======= SFXN1 ======= == Gene Information == * **Official Symbol**: SFXN1 * **Official Name**: sideroflexin 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=94081|94081]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9H9B4|Q9H9B4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SFXN1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SFXN1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/615569|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Might be involved in the transport of a component required for iron utilization into or out of the mitochondria. |Mtc| |D-serine transmembrane transporter activity| |serine import into mitochondrion| |D-serine transport| |L-serine transport| |L-serine transmembrane transporter activity| |D-amino acid transport| |serine transport| |amino acid import| |one-carbon metabolic process| |integral component of mitochondrial inner membrane| |neutral amino acid transport| |L-amino acid transport| |iron ion transport| |amino acid transmembrane transport| |erythrocyte differentiation| |erythrocyte homeostasis| |mitochondrial transmembrane transport| |myeloid cell homeostasis| |amino acid transport| |transition metal ion transport| |carboxylic acid transmembrane transport| |organic acid transmembrane transport| |drug transport| |homeostasis of number of cells| |mitochondrial transport| |myeloid cell differentiation| |anion transmembrane transport| |organic acid transport| |carboxylic acid transport| |organic anion transport| |hemopoiesis| |anion transport| |hematopoietic or lymphoid organ development| |cation transmembrane transport| |metal ion transport| |immune system development| |cation transport| |ion transmembrane transport| |response to drug| |mitochondrion| |transmembrane transport| |ion transport| |homeostatic process| |small molecule metabolic process| |nitrogen compound transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|-2.44| |[[:results:exp34|Rotenone 20μM R00 exp34]]|1.72| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|1.74| |[[:results:exp492|iCRT14 30μM R08 exp492]]|1.75| |[[:results:exp54|Taxol 0.002μM R01 exp54]]|1.84| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|1.92| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|2| |[[:results:exp191|Hypoxia 5%O2 R04 exp191]]|2.03| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|2.27| |[[:results:exp211|AICAR 240μM R05 exp211]]|2.41| ^Gene^Correlation^ |[[:human genes:m:mthfd1l|MTHFD1L]]|0.439| |[[:human genes:s:slc25a32|SLC25A32]]|0.429| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2975 * **Expression level (log2 read counts)**: 7.02 {{:chemogenomics:nalm6 dist.png?nolink |}}